Therapeutic microRNAs targeting the NF-kappa B signaling circuits of cancers

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• Nuclear factor kappa B (NF-κB) signaling is frequently dysregulated in cancer, promoting tumor development and resistance to therapy.
• MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and are often altered in cancer cells, impacting NF-κB activity.
• NF-κB plays a critical role in cancer progression, inflammation, and therapeutic resistance.

Purpose of the Study:

• To review the mechanisms by which miRNAs modulate NF-κB expression and activation in various cancers.
• To examine the therapeutic potential of NF-κB-targeting miRNAs in cancer treatment and as sensitizers for chemo- and radiotherapies.
• To assess the limitations, challenges, and future strategies for developing miRNA-based cancer therapeutics.

Main Methods:

• Literature review of studies investigating miRNA-NF-κB interactions in cancer.
• Analysis of mechanisms underlying miRNA-mediated regulation of NF-κB signaling pathways.
• Evaluation of preclinical and clinical data on the efficacy of NF-κB-targeting miRNAs in cancer models and patients.

Main Results:

• miRNAs can directly or indirectly regulate NF-κB expression and activity through complex signaling networks.
• Altered miRNA expression in cancer is associated with elevated NF-κB activity, contributing to tumorigenesis and treatment resistance.
• NF-κB-targeting miRNAs demonstrate potential as anticancer agents and sensitizers, but challenges like cross-targeting and instability exist.

Conclusions:

• miRNA-mediated regulation of NF-κB is a significant factor in cancer biology and therapeutic response.
• Targeting NF-κB with miRNAs offers a promising therapeutic strategy for cancer, warranting further investigation.
• Overcoming current limitations is crucial for the successful clinical translation of miRNA-based cancer therapies.